Immunosuppressive Therapy in Myelodysplastic Syndromes Is Still Alive

Acta Haematol. 2015;134(3):135-7. doi: 10.1159/000371833. Epub 2015 Apr 24.

Authors

Moshe Mittelman¹, Howard S Oster

Affiliation

¹ Department of Medicine, Tel Aviv Sourasky Medical Center, Sackler Faculty of Medicine, Tel Aviv University, Tel Aviv, Israel.

PMID: 25925850
DOI: 10.1159/000371833

No abstract available

Publication types

Editorial
Comment

MeSH terms

Adjuvants, Immunologic / administration & dosage*
Cyclosporine / administration & dosage*
Female
Humans
Levamisole / administration & dosage*
Male
Myelodysplastic Syndromes / drug therapy*

Substances

Adjuvants, Immunologic
Levamisole
Cyclosporine